CSafe Global and Biocair International have announced the signing of a master lease agreement, which will further enhance Biocair’s healthcare cold chain solutions portfolio.
The portfolio will include the CSafe RKN active temperature controlled aircraft container, which was developed specifically for the life science, pharmaceutical and healthcare industries.
Biocair strategic development director Don Riach said: "As we are moving increasing amounts of clinical trial supplies, APIs and reagents, we are delighted to be able to offer the CSafe RKN as part of our active cold chain solutions.
"I have utilised the CSafe RKN container many times with excellent results and zero temperature excursions.
"The superior insulation properties and extended autonomy time provides both us and our customers with extra peace of mind.
"Working with CSafe will help us to continuously improve and secure the supply chain and create maximum value for our healthcare customers."
CSafe continues to grow to meet customers needs, including new partnerships with major global airlines, forwarders and specialty couriers, additions to the global service network and through the ongoing expansion of their fleet of containers.
The CSafe RKN is the only compressor driven air cargo container of its kind with approvals from both the US Federal Aviation Administration and European Aviation Safety Agency.